XML 36 R25.htm IDEA: XBRL DOCUMENT v3.19.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2019
Summary Components of Stock-Based Compensation Expense

The following table summarizes the components of stock-based compensation expense in the condensed consolidated statements of operations for the three months ended March 31, 2019 and 2018:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2019

 

 

2018

 

Cost of services

 

$

159

 

 

$

164

 

Cost of product sales

 

 

43

 

 

 

39

 

Selling, general and administrative

 

 

1,626

 

 

 

1,292

 

Product development

 

 

254

 

 

 

212

 

Total

 

$

2,082

 

 

$

1,707

 

Time-Based Stock Appreciation Rights [Member]  
Summary of Stock Appreciation Rights

A summary of the Company’s time-based stock appreciation rights (“SARs”) for the three months ended March 31, 2019 is as follows:

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

Aggregate

 

 

 

 

 

 

 

Weighted-

 

 

Remaining

 

 

Intrinsic

 

 

 

Number of

 

 

Average

 

 

Contractual

 

 

Value

 

 

 

Shares

 

 

Exercise Price

 

 

Term (years)

 

 

(In thousands)

 

Outstanding at January 1, 2019

 

 

2,199,094

 

 

$

5.36

 

 

 

 

 

 

 

 

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(6,000

)

 

 

6.09

 

 

 

 

 

 

 

 

 

Forfeited or expired

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at March 31, 2019

 

 

2,193,094

 

 

$

5.30

 

 

 

3.43

 

 

$

2,483

 

Exercisable at March 31, 2019

 

 

2,163,094

 

 

$

5.35

 

 

 

3.37

 

 

$

2,709

 

Vested and expected to vest at March 31, 2019

 

 

2,193,094

 

 

$

5.30

 

 

 

3.43

 

 

$

2,483

 

Performance-Based Stock Appreciation Rights [Member]  
Summary of Stock Appreciation Rights

A summary of the Company’s performance-based SARs for the three months ended March 31, 2019 is as follows:

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

Aggregate

 

 

 

 

 

 

 

Weighted-

 

 

Remaining

 

 

Intrinsic

 

 

 

Number of

 

 

Average

 

 

Contractual

 

 

Value

 

 

 

Shares

 

 

Exercise Price

 

 

Term (years)

 

 

(In thousands)

 

Outstanding at January 1, 2019

 

 

233,496

 

 

$

6.02

 

 

 

 

 

 

 

 

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited or expired

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at March 31, 2019

 

 

233,496

 

 

$

5.96

 

 

 

4.38

 

 

$

974

 

Exercisable at March 31, 2019

 

 

233,496

 

 

$

5.96

 

 

 

4.38

 

 

$

974

 

Vested and expected to vest at March 31, 2019

 

 

233,496

 

 

$

5.96

 

 

 

4.38

 

 

$

974

 

Time-Based Restricted Stock Units [Member]  
Summary of Restricted Stock Units

A summary of the Company’s time-based restricted stock units (“RSUs”) for the three months ended March 31, 2019 is as follows:

 

 

 

Shares

 

 

Weighted-

Average

Grant Date

Fair Value

 

Balance at January 1, 2019

 

 

920,024

 

 

$

9.60

 

Granted

 

 

109,250

 

 

 

8.08

 

Vested

 

 

(358,874

)

 

 

9.78

 

Forfeited or expired

 

 

(5,212

)

 

 

9.87

 

Balance at March 31, 2019

 

 

665,188

 

 

$

9.38

 

Performance-Based Restricted Stock Units [Member]  
Summary of Restricted Stock Units

A summary of the Company’s performance-based RSUs for the three months ended March 31, 2019 is as follows:

 

 

 

Shares

 

 

Weighted-

Average

Grant Date

Fair Value

 

Balance at January 1, 2019

 

 

613,605

 

 

$

9.44

 

Granted

 

 

 

 

 

 

Vested

 

 

(262,685

)

 

 

9.90

 

Forfeited or expired

 

 

(15,332

)

 

 

9.86

 

Balance at March 31, 2019

 

 

335,588

 

 

$

9.46

 

Market Performance Units [Member]  
Fair Value of Stock Appreciation Rights Estimated

As the MPUs contain both performance and service conditions, they have been treated as a series of three separate awards, or tranches, for purposes of recognizing stock-based compensation expense. The Company recognizes stock-based compensation expense on a tranche-by-tranche basis over the requisite service period for that specific tranche. The Company estimated the fair value of the MPUs using a Monte Carlo simulation model that used the following assumptions:

 

 

 

Three Months Ended March 31,

 

 

2019

 

2018

Risk-free interest rate

 

2.22% to 2.43%

 

2.03% to 2.36%

Estimated volatility factor

 

33.0% to 44.0%

 

29.0% to 32.0%

Expected dividends

 

None

 

None